Wells Fargo’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Wells Fargo’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4	Closed	-$31	–	7624
2024 Q1	$31	Hold	4	–	–	﹤0.01%	6977
2023 Q4	$28	Hold	4	–	–	﹤0.01%	7103
2023 Q3	$69	Hold	4	–	–	﹤0.01%	6848
2023 Q2	$101	Buy	4 +1	+33%	+$40	﹤0.01%	6863
2023 Q1	$189	Hold	3	–	–	﹤0.01%	6789
2022 Q4	$72	Hold	3	–	–	﹤0.01%	6890
2022 Q3	$0	Hold	3	–	–	﹤0.01%	7585
2022 Q2	$0	Sell	3 -100	-97%	-$6.9K	﹤0.01%	7697
2022 Q1	$10K	Sell	103 -97	-49%	-$14.7K	﹤0.01%	6277
2021 Q4	$39K	Buy	200 +185	+1,233%	+$28.8K	﹤0.01%	6085
2021 Q3	$3K	Buy	+15	New	+$3.81K	﹤0.01%	6517

Other funds holding TBIO

Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DWS

Dynamic Wealth Strategies Granite Bay, California $188M AUM 18.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo's TBIO Position: Q2 2024 in Review

Wells Fargo sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2024, closing a stake of 4 shares — an estimated $31 sold.

Wells Fargo first reported a position in TBIO in Q3 2021 and held it in 11 quarters. The position peaked at $39K in Q4 2021. 10 funds tracked by Wall St. Rank hold TBIO as of Q2 2024.

Wells Fargo reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Wells Fargo sold 4 Telesis Bio, Inc. Common Stock shares in Q2 2024, an estimated $31.
Wells Fargo first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
Wells Fargo's Telesis Bio, Inc. Common Stock position peaked at $39K in Q4 2021.
10 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.